Sotera Health (SHC) Q4 FY25 earnings call

Sotera Health delivered a strong Q4 and full-year FY25, extending its revenue growth streak and expanding adjusted EBITDA margins. The company is well-positioned for sustained growth in 2026, driven by operational execution and disciplined financial management, despite some segment-specific headwinds related to Cobalt-60 harvest timing and commercial segment choppiness. Management remains committed to its long-range plan and capital allocation priorities.